ADVL1621 A Phase I/II Study of Pembrolizumab (MK-3475) in Children with advanced melanoma or a PD-L1 positive advanced, relapsed or refractory solid tumor or lymphoma (KEYNOTE-051)

  • Goldman, Stewart (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date1/12/178/31/50

Funding

  • Children's Hospital of Philadelphia (WO FP00022186_SUB05_01)
  • Merck Sharp & Dohme Corp (WO FP00022186_SUB05_01)